1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ATP5E CTRPv2 pan-cancer AAC -0.15 3e-06
mRNA RP4-614O4.11 CTRPv2 pan-cancer AAC -0.16 3e-06
mRNA KDM7A CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA EIF6 CTRPv2 pan-cancer AAC -0.16 3e-06
mRNA ZNF253 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA PCDHB11 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA APLP1 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA KIAA1147 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA RMI1 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA GPAT3 CTRPv2 pan-cancer AAC -0.16 3e-06
Download CSV